{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [],
  "article_type": null,
  "arxiv": null,
  "author_total": 258,
  "authors": [
    {
      "name": "Thomas Powles"
    },
    {
      "name": "Tibor Csőszi"
    },
    {
      "name": "Mustafa Özgüroğlu"
    },
    {
      "name": "Nobuaki Matsubara"
    },
    {
      "name": "Lajos Géczi"
    },
    {
      "name": "Susanna Y-S Cheng"
    },
    {
      "name": "Yves Fradet"
    },
    {
      "name": "Stephane Oudard"
    },
    {
      "name": "Christof Vulsteke"
    },
    {
      "name": "Rafael Morales Barrera"
    },
    {
      "name": "Aude Fléchon"
    },
    {
      "name": "Seyda Gunduz"
    },
    {
      "name": "Yohann Loriot"
    },
    {
      "name": "Alejo Rodriguez-Vida"
    },
    {
      "name": "Ronac Mamtani"
    },
    {
      "name": "Evan Yu"
    },
    {
      "name": "Kijoeng Nam"
    },
    {
      "name": "Kentaro Imai"
    },
    {
      "name": "Blanca Homet Moreno"
    },
    {
      "name": "Ajjai Alva"
    },
    {
      "name": "Diana Vera Cascallar"
    },
    {
      "name": "Mirta Varela"
    },
    {
      "name": "Mauricio Fernandez Lazzaro"
    },
    {
      "name": "Diego Lucas Kaen"
    },
    {
      "name": "Gabriela Gatica"
    },
    {
      "name": "David Hugo Flores"
    },
    {
      "name": "Agustin Falco"
    },
    {
      "name": "Matias Molina"
    },
    {
      "name": "Filip van Aelst"
    },
    {
      "name": "Christof Vulsteke"
    },
    {
      "name": "Brieuc Sautois"
    },
    {
      "name": "Jean-Pascal Machiels"
    },
    {
      "name": "Denis Schallier"
    },
    {
      "name": "Leandro Brust"
    },
    {
      "name": "Liane Rapatoni"
    },
    {
      "name": "Sergio Azevedo"
    },
    {
      "name": "Gisele Marinho"
    },
    {
      "name": "Joao Paulo Holanda Soares"
    },
    {
      "name": "Carlos Dzik"
    },
    {
      "name": "Jamile Almeida Silva"
    },
    {
      "name": "Andre Poisl Fay"
    },
    {
      "name": "Joel Gingerich"
    },
    {
      "name": "Yves Fradet"
    },
    {
      "name": "Cristiano Ferrario"
    },
    {
      "name": "Kylea Potvin"
    },
    {
      "name": "Marie Vanhuyse"
    },
    {
      "name": "Mahmoud Abdelsalam"
    },
    {
      "name": "Susanna Cheng"
    },
    {
      "name": "Christian Caglevic"
    },
    {
      "name": "Felipe Reyes"
    },
    {
      "name": "Jose Luis Leal"
    },
    {
      "name": "Francisco Francisco"
    },
    {
      "name": "Carolina Ibanez"
    },
    {
      "name": "Florence Joly"
    },
    {
      "name": "Brigitte Laguerre"
    },
    {
      "name": "Sylvain Ladoire"
    },
    {
      "name": "Aude Flechon"
    },
    {
      "name": "Delphine Topart"
    },
    {
      "name": "Olivier Huillard"
    },
    {
      "name": "Stéphane Oudard"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/er8sbv20nznt0.bib",
  "cited_by": 642,
  "doi": "10.1016/s1470-2045(21)00152-2",
  "fulltext_url": null,
  "id": "er8sbv20nznt0",
  "issns": [
    "1470-2045",
    "1474-5488"
  ],
  "landing_url": "https://hal.science/hal-05742858v1",
  "language": "en",
  "licence": "unknown",
  "licence_label": "Licence not stated",
  "licence_source": "unknown",
  "licence_url": null,
  "metadata_licence": null,
  "native_subjects": [
    [
      "hal",
      "0.sdv"
    ],
    [
      "hal",
      "0.shs"
    ],
    [
      "openalex",
      "2746|Bladder and Urothelial Cancer Treatments"
    ]
  ],
  "openalex": "W3164197656",
  "pdf_url": null,
  "pmcid": null,
  "pmid": null,
  "published": "2026-09-08",
  "publisher": "Elsevier",
  "ris": "https://research.draconitic.com/paper/er8sbv20nznt0.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:17:31Z",
      "native_id": "hal-05742858",
      "source": "hal",
      "url": "https://hal.science/hal-05742858v1"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2746|Bladder and Urothelial Cancer Treatments",
      "subfield": "surgery"
    }
  ],
  "title": "Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial",
  "title_text": "Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial",
  "type": "peer-reviewed",
  "updated_at": "2026-10-30T12:17:31Z",
  "url": "https://research.draconitic.com/paper/er8sbv20nznt0",
  "venue": "Lancet Oncology",
  "versions": []
}